Table 2.
Raw 264.7 | IL-6 mRNA Inhibition (%) | IL-1β mRNA Inhibition (%) | ||
---|---|---|---|---|
Compound | 1 μg/mL | 10 μg/mL | 1 μg/mL | 10 μg/mL |
LPS | 0.0 ± 0.91 | 0.0 ± 0.02 | ||
3a | 33.64 ± 1.05 ** | 44.12 ± 0.25 ** | 89.01 ± 1.19 ** | 95.08 ± 0.88 ** |
3e | 65.03 ± 0.52 ** | 76.10 ± 1.11 ** | 75.55 ± 2.01 ** | 78.75 ± 0.98 ** |
3a + 3e | 40.55 ± 0.71 ** | 45.21 ± 1.03 ** | 82.55 ± 0.77 ** | 83.66 ± 0.90 ** |
** p < 0.01 compared with the group treated with the LPS alone. Data are presented as the mean ± SD.